Clinical Trials Browser

Phase 1/2 × disitamab vedotin × 1 year × Clear all

NCT06966453 2026-03-04

A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms

NCT06957561 2025-05-04

DIVON

Phase 1/2 Not yet recruiting

Urinary Bladder Neoplasms